糖尿病足病和重大临床结果的风险
Michael Fang1, Jiaqi Hu1, Yein Jeon1
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Diabetes research and clinical practice
|June 15, 2023
概括
糖尿病足病 (DFD) 在一般人群中很常见,影响了三分之一的糖尿病患者. DFD显著增加了主要不良结果的风险,包括截肢,心血管疾病,跌倒和死亡.
科学领域:
- 流行病学 流行病学
- 糖尿病学 糖尿病学
- 血管医学 血管医学
背景情况:
- 糖尿病足病 (DFD) 的长期后果尚未得到充分证实.
- 了解DFD的影响对于管理糖尿病并发症至关重要.
研究的目的:
- 调查糖尿病足病 (DFD) 与糖尿病患者一般人群的主要临床结果之间的关联.
- 量化与DFD相关的长期风险.
主要方法:
- 来自社区动脉硬化风险研究的1,428名糖尿病参与者的前性队列分析.
- 追踪了DFD和临床结果 (截肢,心血管疾病,跌倒,死亡) 到2018年.
- 考克斯回归模型被用来评估事件DFD和后续风险之间的关联.
主要成果:
- 在二十年内,DFD的累积发病率为33.3%.
- 患DFD的危险因素包括年龄较大,血糖控制不佳和血管疾病.
- 在诊断DFD后,5年风险是:38.9%的死亡率,25.2%的心血管疾病,14.5%的截肢,13.2%的严重跌倒.
- DFD与所有结果显著相关 (HRs 1.5-34.7).
结论:
- 糖尿病足病 (DFD) 是患有糖尿病的人群中普遍存在的疾病.
- DFD独立地与主要发病率和死亡率的大幅增加有关.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
19
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
19
Diabetes: Symptoms, Diagnosis, and Complications
605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319


